Antibody pairs for use in a rapid influenza a diagnostic test
AssigneeGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
InventorsDennis Joseph CHURCH, Anthony NICHOLS
Life of this patent
Estimating the term…
Abstract
Novel antibody pairs for use in an Influenza A diagnostic test.
Claims27
A matched antibody pair comprising the detection and capture antibodies in a lateral flow immunoassay to detect Nucleoprotein (NP) antigen of Influenza A present in a sample, wherein the antibodies of said matched antibody pair are independently capable of binding to an NP epitope in the region comprising amino acids 1-60 of Influenza A Nucleoprotein.
A ternary complex comprising:
- (a) Influenza A Nucleoprotein (NP);
- (b) a detection antibody conjugated with or otherwise associated with a detectible signal;
- and
- (c) a capture antibody, optionally immobilized on a substrate,
- wherein (b) and (c) are capable of binding an epitope of (a) independently selected in each case from an NP epitope in the region comprising amino acids 1-60 of Influenza A Nucleoprotein.
A lateral flow immunoassay for detecting Influenza A Nucleoprotein (NP) in a sample, comprising:
- (a) a mobile phase comprising a detection antibody conjugated or otherwise associated with a detectible signal, said detection antibody being capable of binding NP to form a binary complex;
- and
- (b) a stationary phase comprising a substrate comprising immunochromatographic material having immobilized thereon a capture antibody, said capture antibody being capable of binding said NP of the binary complex to form a ternary complex, whereby a detectible signal generated by said ternary complex is indicative of the presence of NP in the sample,
- said capture and detection antibodies being capable of binding an NP epitope in the region comprising amino acids 1-60 of Influenza A Nucleoprotein.
A method for detecting Influenza A in a sample using a lateral flow immunoassay comprising a mobile phase and a stationary phase, said method comprising
- (a) introducing said sample to the mobile phase of said assay,
- (b) contacting Influenza A Nucleoprotein (NP) in said sample with at a detection antibody that is conjugated or otherwise associated with a detectible signal to form a binary complex comprising said detection antibody and NP in said mobile phase, and
- (c) contacting said mobile phase with a stationary substrate comprising immunochromatographic material having immobilized thereon a capture antibody, said capture antibody being capable of binding said NP of the binary complex to form a ternary complex, whereby a detectible signal generated by said ternary complex is indicative of the presence of NP in the sample,
- wherein said capture antibody and said detection antibody are capable of binding an NP epitope in the region comprising amino acids 1-60 of Influenza A Nucleoprotein.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.